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announcements
Holiday party is December 8. After

a two-year hiatus, the universitywide holiday celebration is back. All
are invited to Weiss Café from 3:30
to 5 p.m. for food and beverages.
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OBITUARY

Nobel laureate Ralph Steinman dies at 68
by ZACH VEILLEUX

Happy anniversary. At an afternoon reception on October 27, the
university celebrated employment
anniversaries for 147 members of
the community who had reached
10 years of service in 2009, 2010 or
2011. For a list of the names of the
10-year honorees, see benchmarks.
rockefeller.edu/anniversary. Employees who have reached longer
milestones will be recognized in the
spring.
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Bags for sale. Rockefeller reusable shopping bags are available
for $3.25 each from the Weiss and
CRC coffee carts. The sturdy, lightweight nylon bags are the size of a
plastic grocery bag and fold into an
attached pouch for storage. Carry
one on your errands to help reduce
waste.
Holiday Lectures are December
27. This year’s Rockefeller Univer-

sity Holiday Lectures on Science
for High School Students, begun
in 1959 by Alfred E. Mirsky, a
biochemist and university librarian, will feature Sarah Schlesinger
and Marina Caskey from Ralph
Steinman’s lab. About 400 students
from schools around the city attend
the lectures each year. This year’s
lectures are entitled “Not Just
Another Macrophage: How Ralph
Steinman’s Controversial Discovery
of the Dendritic Cell Slowly Transformed Immunology.” Tickets are
required. For more information, call
Gloria Phipps at x8967.

Announcements for this page may be
submitted to zveilleux@rockefeller.edu.
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Laboratory legacy. The microscope with which Ralph Steinman made his discovery of dendritic cells in 1972.

Ralph Steinman, an immunologist who
spent his entire career at Rockefeller and
died just days before the Nobel Prize committee announced his name, passed away
on September 30 after a four-and-a-half
year battle with pancreatic cancer. Dr.
Steinman, who discovered dendritic cells
with Rockefeller immunologist Zanvil
Cohn in 1972, spawned an entire branch
of immunology devoted to understanding
how the immune system is coordinated and
how it learns to recognize infectious microorganisms and tumor cells. His recent work
led to the development of an experimental
human vaccine for HIV which began clinical testing last year.
Born in Montreal, Canada, in 1943,
Dr. Steinman developed an interest in
science at a young age, and he pursued it
at McGill University and then Harvard
Medical School. Although he trained to
be a physician, he was drawn to research,
and ultimately to Rockefeller, where he
joined the laboratory of Dr. Cohn and
James Hirsch — the Laboratory of Cellular
Physiology and Immunology — in 1970. It
was just a few years later that he made the
landmark discovery that would define his
scientific career.
Immunologists at the time had known
there must be a cell that acted as a coordinator of the immune system — that would
collect antigenic substances from foreign
invaders such as bacteria and viruses and
present them to B cells and T cells that
carry out the dirty work of destroying the
unwelcome guests. Scientists assumed this
was primarily the work of macrophages.
But while investigating the production
of antibodies in the spleen, Dr. Steinman
noticed an unusual cell that acted like a
macrophage but didn’t look like one.
“Ralph coined the term ‘dendritic cell’

in 1973 because he thought the cells he
discovered looked sort of like bare tree
branches,” says Carol Moberg, a senior
research associate who has worked in Dr.
Steinman’s lab since 1987. “But over the
years he often suggested alternate labels. He
proposed ‘novel cell’ for its independence,
‘antigen presenter,’ ‘sentinel,’ ‘orchestrator,’
‘controller,’ ‘nature’s adjuvant’ and, possibly
inspired by his granddaughter’s favorite
movie, Ratatouille, ‘a pilot light for a
kitchen of fantastic immunological chefs.’”
For most of the 1970s, dendritic cells
were, to put it mildly, underappreciated.
Dr. Steinman himself was initially unaware
of the significance of his finding. However,
his dedicated examinations of the cell over
the next several years revealed not a minor
player but one that had been quietly running the show the whole time. Dr. Steinman
showed that dendritic cells, not macrophages, are the main T cell-stimulating
cells, and later demonstrated that they also
stimulate B cells and NK cells. And the field
of immunology reacted with silence and
occasional ridicule.
“The idea that a new type of immune
cell could be found in 1973 — in the era of
molecular cell biology — simply by looking
down a microscope seemed far-fetched, and
the early criticism was relentless,” recalls
Michel Nussenzweig, Dr. Steinman’s first
student and current head of Rockefeller’s
Laboratory of Molecular Immunology.
“This put Ralph in the position of being
not only the dendritic cell’s discoverer, but
its advocate and cheerleader, and he spent
much of his energy in those early years
lobbying his colleagues to recognize its importance. That he ultimately succeeded is a
testament to his forceful personality, energy
and persistence.”
Dr. Steinman pursued the promise of

dendritic cells for the rest of his career,
and he built a great many collaborations
with immunologists and scientists working in other fields. His in vivo studies in
the 1990s found that immature dendritic
cells position themselves at places in the
body that are most vulnerable to invasion
by microbes — the skin, the nasal passages and throat, the intestines, the genitals
— and wait until they are needed. Then,
as soon as a dendritic cell takes its first
antigen prisoner, an incredible maturation
process takes place in which its armor is
strengthened and its antigen-presenting and
signaling capabilities increase.
More recently, he focused a great deal of
attention on the promise of dendritic cells
to treat and prevent disease. The ability of
dendritic cells to defend the body against
autoimmunity might be channeled for use
in the treatment of allergies, transplantations and autoimmune diseases like type 1
diabetes, multiple sclerosis and psoriasis.
Moreover, the techniques developed by
Dr. Steinman to work with dendritic cells
effectively in a test tube have enabled the
development of therapeutic dendritic-cell
vaccines for various types of cancer and
preventive vaccines for HIV.
“Ralph was led by the science and
although he had his biases and direction,
he always let the data drive things,” says
Maggi Pack, a senior research associate
who worked with Dr. Steinman for over
33 years. “He was objective, optimistic and
never seemed to get discouraged.”
Eventually, with persistence, Dr. Steinman won not only the respect of his field,
but also their commendation. In recent
years he was the recipient of several of the
most prestigious prizes in biomedicine,
including the Gairdner Foundation
continued on page 4
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Fundraising campaign concludes with $628 million
by ZACH VEILLEUX
The Rockefeller University Campaign for
Collaborative Science, the fundraising
effort launched to raise support for the
initiatives of the strategic plan developed
at the beginning of Paul Nurse’s presidential tenure, concluded in June having raised $628 million in new gifts and
grants — far surpassing the $500 million
goal set in 2003.
“The university has had tremendous
success raising money to pay for the ambitious proposals laid out in Paul’s plan, and
it’s because of the generosity of the many
donors who contributed to this campaign
that Rockefeller is fiscally strong,” says
Russell C. Carson, chair of the Board of
Trustees. “We are well-positioned to write
the next chapter of the university’s history,
under the leadership of Marc TessierLavigne.”
The most visible element of the recent
campaign is the construction of the
125,000 square foot state-of-the-art Collaborative Research Center. Gifts to the
campaign have also helped to support
the university’s year-to-year operations,
allowed for the recruitment of 12 new faculty members and funded numerous other
initiatives, including an expanded fellows
program and new resource centers. In
addition, campaign gifts to the university’s
endowment have strengthened its long-

term financial outlook. (See chart, right.)
Of the $628 million contributed in support of the campaign, $152 million came
in the form of unrestricted funds to help
underwrite the cost of constructing the
Collaborative Research Center. Members
of Rockefeller’s Board of Trustees contributed a significant portion of the unrestricted funds. Gifts to the endowment totaled
$125 million.
In all, more than 4,000 donors made
nearly 12,000 gifts to the university.
Among them were 92 gifts of at least $1
million, including 11 gifts of $10 million
or more. David Rockefeller, honorary
chair and a trustee of the university for
over 70 years, committed more than $100
million to the campaign, making the largest single private gift in the university’s
history. The Starr Foundation made several grants, including one of $50 million,
the largest foundation grant ever received
at Rockefeller.
“The university is blessed with benefactors who are passionate about science
and who understand that an investment
in science at Rockefeller can yield incalculable benefits to human health,” says
Vice President for Development Marnie
Imhoff. “In addition, many of our friends
have been generous with their time as well
as their financial resources. The univer-

Campaign gifts by broad purpose: $628M
New and current faculty
$158M
Expendable fellowship support
$25M
Endowment support
$125M
Hospital programs and support
$50M
North campus construction
$165M
Unrestricted support
$105M

sity’s Board of Trustees, The Rockefeller
University Council and the Committee
on Trust and Estate Gift Plans, as well as
active volunteer groups such as Women &
Science, Parents & Science and Bridges to
Better Medicine, have all been essential to
the success of the campaign.”
The Campaign for Collaborative Science was the most ambitious fundraising
effort in the university’s history. “Philanthropy to Rockefeller was taken to an
entirely new level,” notes Trustee Judith

Berkowitz, chair of the Board’s development committee. “Our trustees and friends
have been extraordinarily supportive
of our campaign, especially in years of
economic uncertainty. Because of their
commitment and generosity, the future of
the university looks brighter than ever.”
Dr. Tessier-Lavigne is currently working
closely with a campus committee to draft
a new strategic plan for the university, and
a new fundraising campaign linked to its
proposals will be unveiled in 2012.

Small 2011 surplus to help plug future deficits
University’s $325 million operating budget closes with $1 million to spare
by ZACH VEILLEUX

FY2011 total revenues: $325.3M

2.499999

a time lag of three years, the declines we
suffered in fiscal year 2009 will still be
most significantly felt in fiscal year 2012
and beyond,” Mr. Lapple says.
The university’s fiscal year 2011
revenues, which totaled $325.3 million,
come from three primary sources: grants
and contracts from the government and
private sources; income from the university’s endowment; and private fundraising efforts. Although spending from the
endowment was down significantly, reflecting steep losses suffered in 2009, an
especially good year for private fundraising made up some of the difference (see
chart, below left). Government grants
were up compared to previous years as
a result of federal stimulus spending,
and private grants were down slightly.
Income from other sources, including
license and royalty fees paid for the use
of university-owned intellectual property,
was also up.
On the expenditures side of the ledger
(see chart, below right), which totaled
$324.2 million, fiscal year 2011 saw
an uptick in research spending — the
destination of those stimulus dollars —
and debt service, which rose, as expected,
because of bonds issued to finance a
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$42.0M 8 percent from 2010

2.499999

3/11

9/10

3/10

9/09

3/09

9/08

3/08

9/07

3/07

9/06

3/06

2.066666

1.200000

$1.419

9/05

Strong fundraising, access to federal
stimulus funds and better-than-expected
royalty income led the university to close
the 2011 fiscal year with a $1.1 million
surplus, but the approved 2012 budget
is in a deficit position, according to Jim
Lapple, vice president for finance.
“The university’s financial picture was
stable in 2011 — our faculty competed
strongly for federal stimulus grants and
we had an excellent year for fundraising
— but we are continuing to feel the effects of the 2009 economic turmoil,” says
Mr. Lapple. “For that reason, with the
Board’s approval, we have aggregated the
fiscal year 2011 surplus with surpluses
from fiscal years 2009 and 2010 in a
reserve fund that will be used to address
projected shortfalls in future budgets.”
This reserve fund, now totaling
nearly $16 million, will be critical to
help stabilize the university’s budget as
spending from the endowment continues
to decrease, Mr. Lapple says. Spending
from the endowment — which accounts
for approximately one-third of the
university’s overall revenue — is based
on a formula that considers the 12 most
recent quarterly average market value figures. “Because the formula incorporates

portion of the construction of the Collaborative Research Center. Administrative
costs held steady.
In fiscal year 2012, the university is
projecting a $6.9 million deficit despite
the fact that expenditures will be down
significantly, to just $305.6 million. “As
with fiscal year 2011, the main factors

are stimulus funding, which is tapering
off, and endowment income, which will
decline eight percent, from $97 to $89
million,” says Mr. Lapple. “Since this is
the last year in which the endowment
losses from 2009 will be felt, we expect
that endowment spending will stabilize,
or potentially increase, in future years.”

FY2011 total expenditures: $324.2M

2 percent from fiscal year 2010

Research and education
$201.4M 2 percent from 2010
Facilities and administrative overhead
$54.8M 4 percent from 2010
Auxiliaries (food serv., housing, press)
$24.4M unchanged
Debt service
$37.6M 14 percent from 2010
Deferred maintenance
$6.0M 25 percent from 2010

Flexner and Welch Halls now fully gutted
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New planters enhance
pedestrian safety

down to exposed steel so that new concrete floors could
be poured — over the years, many modifications had been
made to parts of the basement, leaving a confusing warren of rooms that were not even all on the same level. In
the stairwell and main reading rooms, protective plywood
(above right) has been laid to preserve the marble and
paneling while work on the floors, windows and ceilings
progresses. Outside, the painstaking piece-by-piece repair
of stonework and masonry is nearly complete.
“Both projects are proceeding as planned, and we are
getting to the point where we are able to visualize how
these gracious spaces will be transformed,” says George
Candler, associate vice president for planning and construction.

CAMPUS NEWS

CAMPUS NEWS

University helps found
New York Genome Center
by JOSEPH BONNER
The Rockefeller University, with 10 of the
country’s leading medical and research
institutions, has joined the New York Genome Center (NYGC), which will become
one of the largest genomic facilities in
North America. The consortium establishes
an unprecedented, large-scale collaborative
venture in genomic medicine.
The NYGC is a nonprofit, academic consortium, similar to the New York Structural
Biology center, but on a larger scale and with
a broader scope, says Robert B. Darnell,
Robert and Harriet Heilbrunn Professor.
Dr. Darnell was a member of the founding
board of directors and is now a member of
the NYGC’s executive board of directors.
Each founding academic institution
contributed $2.5 million, and in return
receives reagents and equipment at the
lowest possible cost, access to cutting edge
technology and priority access to bioinformatics and computational scientists. In
addition, scientists and physicians from
member institutions will share diverse
clinical and genomic data to discover the
molecular underpinnings of disease, identify and validate biomarkers and accelerate
development of novel diagnostics and targeted therapeutics to improve clinical care.
The center will begin operations as early as
spring 2012. Its 120,000-square-foot facility, designed by Elkus Manfredi Architects,
will be located in Manhattan.
“In the decade since the human genome
was sequenced, the application of high
throughput sequencing and other genomic
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Although the removal of concealed asbestos caused some
delays last spring, the reconstruction of Flexner and
Welch Halls is still on schedule, with work on both projects expected to be complete by the end of fall 2012.
In Flexner, framing and utility work (top) is now
underway on several floors. Heads of the laboratories that
will be housed in the renovated space have had the opportunity to fine-tune the designs for their spaces. Heavy
equipment to handle climate control and ventilation systems is being delivered over the next several weeks, and
finishing work including flooring, cabinetry and fixtures is
expected to begin in the spring.
The major work in Welch Hall is now taking place on
the A and B levels (above left), which have been stripped

Hundreds of pedestrians enter campus via the 66th Street
gate each day. So do more than 200 cars, several dozen
delivery vehicles and a steady stream of bicycles. It’s a lot
of traffic for a ten-foot wide driveway and two narrow
sidewalks.
In response to complaints about conﬂicts between
the entrance’s two-legged and four-wheeled users, the
university has recently made several structural changes to
the sidewalks and landscaping just outside the main gate.
The work, which was restricted to university-owned property
immediately adjacent to the city’s sidewalk, is to make it
easier for pedestrians to get on and off of campus without
interfering with vehicular traffic.
“The purpose of the new design is to encourage pedestrians coming onto campus to enter through the pedestrian
gates, and not to walk in the driveway,” says Alex Kogan,
associate vice president for plant operations, which was
responsible for the work. “This will help improve safety and
security for everyone.”
Two planters lining both sides of the driveway are to divert foot traffic away from the street and onto the sidewalks.
Meanwhile, ramps have eliminated the step at both pedestrian entrances, to make it easier for those with strollers or
suitcases. Still to come: a new speed hump, shorter and
wider than a speed bump, to force drivers to pass through
the gate slowly.
“Wherever you have cars and people competing for the
same space you have the potential for an accident, and in
this case blind spots created by the brick pillars make the
situation worse,” says Jim Rogers, director of security. “The
new landscaping is helping to keep people separate from
cars and trucks, and is reducing the likelihood of a serious
incident.”

tools has led to great advances in identifying the genetic drivers of several cancers
and other diseases, and is dramatically accelerating the development of new drugs for
these conditions,” says Rockefeller President Marc Tessier-Lavigne. “The New York
Genome Center will enable us to apply
these powerful tools even more broadly to
extend this success to many other diseases.”
Joining Rockefeller are Cold Spring
Harbor Laboratory, Columbia University,
Cornell University/Weill Cornell Medical
College, Memorial Sloan-Kettering Cancer
Center, Mount Sinai Medical Center,
NewYork-Presbyterian Hospital, New
York University/NYU School of Medicine,
North Shore-LIJ Health System, The Jackson Laboratory and Stony Brook University. The Hospital for Special Surgery is an
associate founding member.
“The New York Genome Center represents the largest collaboration to date
among New York City-based biomedical
and clinical research organizations. It will
position its institutional partners to be at
the forefront of the rapidly evolving field
of genomic science and enhance the city’s
position as one of the foremost centers for
medical research,” says Russell C. Carson,
chair of Rockefeller’s Board of Trustees,
who also serves as chair of the New York
Genome Center.
In addition to Mr. Carson, Dr. TessierLavigne and Dr. Darnell, leadership of the
NYGC includes Rockefeller Trustees James
H. Simons and Anthony B. Evnin.

Rockefeller walkers travel over 100,000 miles
New York is a walking city, especially here
on the far East Side, two-thirds of a mile
from the subway. Count all those steps —
getting to work, to lunch, to the market —
and the distance can really add up.
This summer, 189 university employees participated in the Global Corporate
Challenge (GCC), a worldwide walking
program in which participants are issued
pedometers and record their daily step
totals on a dedicated Web portal.
Over 16 weeks, the participants walked
a total of 269,705,477 steps. That translates to 107,256 miles, or 4.3 trips around
the world. They burnt 10,874,525 calories and, by choosing to walk instead of

drive, ride the bus or take an elevator, they
prevented 14,270 pounds of carbon from
entering the atmosphere. The average daily
distance walked per person: 5.94 miles.
“Although we have sponsored walking
programs at Rockefeller in the past, this
was the first year that we joined an outside
program and got the benefits of Web-based
data tracking and incentives,” says Ginny
Hansen, director of benefits. “It was more
fun for the participants, and GCC’s data
collection allowed us to see just how much
of a difference the program can make in
people’s habits and in their health.”
Registration for the 2012 program will
begin in late April.

Where glass gets clean
www.rockefeller.edu/video/glasswashing

The university’s newly refurbished Glasswashing Services center cleans, dries and sterilizes around
4,000 pieces of laboratory glassware from 52 labs each week. Watch this video to meet the workers and see how it’s done.

Nobel laureate Ralph Steinman dies at 68 (continued from page 1)
The potential of dendritic cell-based vaccines is just
now becoming apparent and clinical trials to better understand their therapeutic effects have begun in only the past
few years. “Although Ralph did not live long enough to
see his discovery win the Nobel, he did live to see vaccines based on his discovery used in real human patients,
something that did not occur until after his diagnosis,” says
Dr. Schlesinger. “He was thrilled to finally see the clinical
impact of his work.”
“I had the opportunity to meet
Ralph a number of times over the
years,” says Russell C. Carson, chair
of the university’s Board of Trustees.
“Each time I did so, I was struck by not
only his obvious intelligence but even
more so by what a nice person he was.
He had a keen interest in other people
and he enjoyed talking about a wide
variety of subjects. I’m sure a large part
of his success in the scientific community came from his intellectual curiosity
and his ability to both learn from and
mentor others.”
“Ralph truly embodied the spirit
of what sets Rockefeller apart,” says
Marc Tessier-Lavigne, the university’s
president. “He was a risk taker and a
pioneer, who believed in his findings
even when others did not, as well as
a careful and precise scientist whose
steadfast pursuit of the workings of
dendritic cells led him to have an outsized impact on his field.”
Dr. Steinman, a resident of Westport,
Connecticut, is survived by his wife of
40 years, Claudia, and three children: Adam, a law professor who resides in Brooklyn; Alexis, a costume designer
based in Los Angeles; and Lesley, a social worker and
researcher at the University of Washington in Seattle. He
had three grandchildren.
“It will be a long time, if ever, before we feel that Ralph
isn’t here,” says Dr. Pack. “His presence has been so powerful and his legacy will be so strong that a part of him will
always live with us at Rockefeller.”
PHOTOS: COURTESY STEINMAN FAMILY

International Award, the Albert Lasker Basic Medical
basis for individualized therapy) and received traditional
Research Award and the Albany Medical Center Prize. And
chemotherapy, followed by a course of eight experimental
finally, this October 3, 38 years after his landmark publicaimmunotherapies in succession.
tion, Dr. Steinman’s phone rang at 5 a.m. with the news
Dr. Steinman’s life post-diagnosis was a relatively
that he would receive one-half of the 2011 Nobel Prize in
healthy one, a fact that he also attributed to his immunoPhysiology or Medicine — the ultimate recognition of his
therapy. He felt well most of the time, and continued to
life’s work and vindication for all those early years when
work until the very end. He was vigorous enough to travel
only he and a few close collaborators believed in it.
to conferences, and spent a great deal of time and effort to
Sadly, the news came three days too
late for Dr. Steinman to hear it.
Diagnosed with pancreatic adenocarcinoma in March 2007, Dr. Steinman’s original prognosis was poor. By
the time it was detected — when Dr.
Steinman went to see his doctor complaining of digestive distress and painless jaundice — the cancer had already
spread beyond the pancreas. The one
year survival rate for this type of cancer
is just 25 percent and the average life
expectancy about six months. But
dendritic cells had the potential to fight
exactly this type of aggressive tumor,
and Dr. Steinman had access to brilliant
collaborators and leading edge technology. He set about designing a course of
therapy that he hoped would extend his
life in a way that conventional chemotherapy might not be able to.
“He approached it the same way
he approached any experiment,” says
Sarah Schlesinger, research associate
professor and head of Dr. Steinman’s
Dr. Steinman in 1971 (left) and in 2009.
clinical research program. “He worked
with colleagues worldwide to arrive at
a plan for treating the cancer, and he designed the therapy
ensure that everyone in his busy lab had a path forward afin a way that he hoped would allow us to learn someter he was gone. He was reviewing data — he was always
thing as he was being treated.” The Rockefeller University
eager to review data — just days before his death.
Hospital established a new clinical protocol, IRB and FDA
“We’ll never know for sure how much he was helped by
approval was obtained, and Dr. Steinman formally became
the experimental therapies he received,” says Dr. Schlesinga clinical trial of one.
er, who was closely involved in his care. “Scientifically it’s
He had surgery (the tumor itself, once removed, was
just not possible to draw conclusions from a single patient.
divided, preserved and sent to the labs of Dr. Steinman’s
But he certainly enjoyed a longer and healthier life than the
contemporaries all over the world to be used as the
odds would suggest.”

Milestones
PROMOTIONS, AWARDS AND PERSONNEL NEWS

Awarded:
Leslie B. Vosshall, the 2011 Gill Young Inves-

tigator Award from the Linda and Jack Gill
Center for Biomolecular Science at Indiana
University, Bloomington. The award recognizes exceptional scientists who have emerged as
international leaders in cellular, membrane or
molecular neuroscience. Dr. Vosshall is Robin
Chemers Neustein Professor and head of the
Laboratory of Neurogenetics and Behavior, as
well as a Howard Hughes Medical Institute
investigator.

Michael W. Young, the 2011 Louisa Gross

Horwitz Prize from Columbia University.
He shares the prize with Jeffrey C. Hall and
Michael Rosbash for their work on the molecular basis of circadian rhythms, the first
demonstration of a molecular mechanism for
behavior. The Horwitz Prize recognizes outstanding basic research in the fields of biology
or biochemistry. Dr. Young is Richard and
Jeanne Fisher Professor and head of the Laboratory of Genetics.

Elected:
Cori Bargmann, associate member of the

European Molecular Biology Organization,
which promotes excellence in and helps shape
the direction of molecular life sciences in
Europe. Dr. Bargmann is Torsten N. Wiesel
Professor and head of the Lulu and Anthony
Wang Laboratory of Neural Circuits and Behavior, as well as a Howard Hughes Medical
Institute investigator.
Marc Tessier-Lavigne, to the Institute of

Medicine, the health and medicine branch of
the National Academy of Sciences. Sixteen
Rockefeller University scientists are Institute
of Medicine members. Dr. Tessier-Lavigne is
head of the Laboratory of Brain Development
and Repair.

Elected:
Jeffrey M. Friedman, to the Rensselaer Polytechnic Institute Alumni Hall of Fame. Dr.

Friedman, a 1977 graduate of RPI, is Marilyn
M. Simpson Professor and head of the Laboratory of Molecular Genetics, as well as a Howard Hughes Medical Institute investigator.
Gaby Maimon, one of Popular Science maga-

zine’s “Brilliant Ten,” a selection of promising
young researchers under 40 who represent the
best of what science can achieve. Dr. Maimon
was profiled in the September issue of the
magazine. He is head of the Laboratory of
Integrative Brain Function.

Hired:

Ingrid Fetter Pruneda, visiting student,

Dominik Paquet, postdoctoral fellow, Tessier-

Natalia Freund, postdoctoral associate,

Maria Pardos de la Gandara, postdoctoral

Kronauer Lab.

Nussenzweig Lab.

Maura Gilmartin, senior grants management

specialist, Sponsored Research and Program
Development.

Lavigne Lab.

associate, Tomasz Lab.

John Pena, visiting fellow, Tuschl Lab.
Alexander Petroff, fellow in physics and

biology, Center for Theoretical Studies.

Simona Giunta, postdoctoral associate,

Vanessa Ruta, assistant professor and head of

Jason Gray, postdoctoral fellow, McEwen Lab.

Sabrina Sell, visiting student, Nussenzweig

Funabiki Lab.

Qi Hao, visiting student, Kapoor Lab.

laboratory, Ruta Lab.

Lab.

Margaret Herre, research assistant, Robert

Ji-Seon Seo, postdoctoral associate,

Robert Houghtaling, special events coordina-

Dese’Rae Stage, administrative assistant,

Darnell Lab.

Greengard Lab.

Bushra Amreen, research assistant, Konarska

tor, Communications and Public Affairs.

Ursula Andreo, postdoctoral associate, Rice

Karin Hultman, postdoctoral fellow,
Strickland Lab.

Lab.

Heeun Jang, postdoctoral associate,

Bryan Utter, postdoctoral associate, Fischetti

Yildiz Kelahmetoglu, research assistant,

Maria Valerio, animal health technician I,

Lab.

Lab.

Karen Andres, development assistant I,

Development.

Sandra Appadu, visiting student, McEwen

Lab.

Bartlomiej Blus, postdoctoral associate,

Blobel Lab.

Cordula Boehm, visiting fellow, Rout Lab.

Bargmann Lab.

Greengard Lab.

Sarah Klass, administrative assistant, Leibler

Lab.

Ralph Kleiner, postdoctoral fellow, Kapoor

Libchaber Lab.

Hanna Sundelin, visiting student, McEwen

Lab.

Comparative Bioscience Center.

Ellen van Wilgenburg, visiting fellow,

Kronauer Lab.

Shali Zhang, visiting medical student, Krueger

Lab.

Lab.

Pamela Carpentier, associate editor, JCB,

Matthew Koletsky, research assistant, Allis Lab.

Pingzhi Zhao, visiting student, Chua Lab.

Zachary Charlop-Powers, postdoctoral

Tuschl Lab.

Rockefeller University Press.

associate, Brady Lab.

Gist Croft, postdoctoral associate, Brivanlou

Lab.

Christopher Cush, mail room clerk, Mail

Room.

Julien Dervaux, postdoctoral fellow,
Libchaber Lab.
Margaret Ebert, postdoctoral associate,

Bargmann Lab.

Caroline Eden, research assistant,

Nussenzweig Lab.

Hampus Edgren, foreign research intern,

Stebbins Lab.

Robyn Eisert, postdoctoral associate, Hang

Lab.

Felix Evers, foreign research intern, Stebbins

Lab.

Carl Leonhardt, foreign research intern,

Orlee Zorbaron, laboratory administrator,

Roeder Lab.

Wei Li, postdoctoral fellow, Chua Lab.
Sean Low, postdoctoral associate, Hudspeth

Lab.

Jose Marques Lopes, visiting fellow, McEwen

Promoted (academic appointments):
Stephanie Boisson-Dupuis, to senior research

Lab.

associate, Casanova Lab.

Henrik Molina, research assistant professor
and director, Proteomics Resource Center.

Edgar Charles, to assistant professor of

Daniel Neer, office administrator, General

Ivan Marazzi, to research associate,
Tarakhovsky Lab.

Counsel.

Hanna Ning, foreign research intern, Krueger

Lab.

clinical investigation, Rice Lab.

Peter Stavropoulos, to research associate,

Papavasiliou Lab.

Mary O’Donnell, human resources generalist,
Human Resources.
Anna Olofsson, foreign research intern,
Casanova Lab.
Kimberly Olsen, senior research associate,
Tessier-Lavigne Lab.

This publication lists new hires, awards and
promotions. Staff promotions are listed yearly;
academic promotions and appointments are
listed monthly.

